Bronchiolitis - Supportive Care and High Flow Nasal Cannula

Key Points

• Bronchiolitis is a clinical diagnosis; routine viral panels, chest radiographs, and blood tests are unnecessary in typical cases.
• Supportive care with suctioning, hydration, and oxygen when needed is the treatment foundation.
• Routine bronchodilators and corticosteroids are not recommended for classic bronchiolitis.
• High-flow nasal cannula is an escalation tool for selected infants, not an automatic first-line therapy.
• Young age, prematurity, chronic lung or heart disease, neuromuscular weakness, and immunocompromise increase risk.
• Feeding ability is part of respiratory assessment because tachypnea and fatigue can make oral intake unsafe.
• Recurrent apnea, rising oxygen need, fatigue, or altered mental status should trigger higher-acuity care.

Algorithm

1. Confirm the typical sequence of viral upper-respiratory symptoms followed by lower-airway findings in an infant.
2. Assess respiratory effort, oxygen saturation, apnea risk, hydration, and feeding.
3. Use gentle nasal suctioning and maintain enteral hydration when safe.
4. Give low-flow oxygen for persistent clinically important hypoxemia.
5. Escalate to HFNC when significant distress or oxygen need persists despite standard measures, following local weight-based flow protocols.
6. Reassess for HFNC failure and move to noninvasive ventilation or intubation if the child is tiring or gas exchange worsens.
7. Avoid routine albuterol, corticosteroids, antibiotics, and chest radiography unless the presentation suggests another diagnosis.
8. Discharge when breathing, oxygenation, hydration, and caregiver support are all stable.

Clinical Synopsis & Reasoning

Bronchiolitis most commonly affects children younger than 2 years, with the greatest risk of severe disease in young infants. RSV is a leading cause, but rhinovirus, human metapneumovirus, influenza, parainfluenza, adenovirus, and other viruses can produce the same clinical syndrome. Illness typically begins with nasal congestion and rhinorrhea, then progresses over several days to cough, tachypnea, wheezing, crackles, feeding difficulty, and increased work of breathing. The diagnosis is clinical. The key reasoning task is not to identify a particular virus but to determine whether the infant can maintain oxygenation, ventilation, hydration, and feeding without exhausting.

Severity assessment should include respiratory rate, retractions, nasal flaring, grunting, air entry, oxygen saturation, mental status, hydration, and ability to feed. Apnea can be the presenting manifestation in very young infants. Prematurity, age under about 12 weeks, chronic lung disease, hemodynamically significant congenital heart disease, neuromuscular weakness, and immunocompromise increase the chance of severe illness. Oxygen saturation should be interpreted together with the clinical picture, because brief desaturations during sleep can occur and continuous oximetry can prolong hospitalization if every transient low value triggers intervention.

Routine chest radiography is discouraged because peribronchial thickening, atelectasis, and hyperinflation can be mistaken for bacterial pneumonia and drive unnecessary antibiotics. Viral testing is generally unnecessary for individual treatment, though it can have infection-control or cohorting value. Blood tests are not routinely required. Consider another diagnosis when fever is unusually high, focal lung findings persist, the course is prolonged, there is recurrent focal wheeze, the child has poor growth, or the episode occurs outside the expected age pattern. Important alternatives include bacterial pneumonia, asthma or recurrent viral wheeze, heart failure, airway foreign body, pertussis, cystic fibrosis, and congenital airway or cardiac disease.

Treatment Strategy & Disposition

Supportive care is the standard. Gentle nasal suctioning can improve feeding and work of breathing when upper-airway secretions are prominent; deep repetitive suctioning can cause trauma and is not routinely needed. Continue breast or bottle feeding in small frequent amounts when respiratory effort permits. Use nasogastric or intravenous fluids when oral intake is inadequate or tachypnea makes feeding unsafe. Avoid excessive fluid because bronchiolitis can be associated with inappropriate antidiuretic hormone secretion and because fluid overload can worsen respiratory mechanics.

Give supplemental oxygen for persistent clinically important hypoxemia. Different institutions use slightly different thresholds, but AAP guidance permits an oxygen-saturation target around 90% in otherwise stable infants. Low-flow nasal cannula is usually the first escalation. High-flow nasal cannula can reduce work of breathing and provide some distending pressure in infants who remain significantly distressed or hypoxemic despite conventional oxygen. It should be used with a defined escalation protocol and close reassessment, because HFNC does not guarantee protection from apnea or respiratory failure. Failure is suggested by worsening tachypnea, persistent severe retractions, rising carbon dioxide, recurrent apnea, increasing oxygen requirement, fatigue, or altered mental status. Noninvasive positive-pressure ventilation or intubation may be required in severe disease.

Routine albuterol, epinephrine, systemic or inhaled corticosteroids, hypertonic saline in the emergency department, and antibiotics do not improve typical bronchiolitis outcomes enough to justify routine use. A carefully observed bronchodilator trial is sometimes considered when the diagnosis is uncertain and an older infant has a strong recurrent-wheeze or atopic phenotype, but continuation should depend on a clear objective response rather than habit. Antibiotics are reserved for a proven or strongly suspected bacterial infection. Discharge is appropriate when work of breathing is mild and stable, oxygenation is acceptable without escalating support, hydration is adequate, caregivers can manage nasal secretions and feeding, and follow-up is reliable.

Epidemiology / Risk Factors

• Bronchiolitis is a leading cause of hospitalization in infants.
• RSV causes a large share of cases, but clinical management is usually similar regardless of the virus identified.
• Peak illness often occurs around days 3 to 5 of symptoms.
• Severe disease is concentrated in very young infants and children with important cardiopulmonary or neurologic comorbidities.

Investigations

Admission Clues

Pharmacology

Prognosis / Complications

• Most infants recover with supportive care over one to two weeks, although cough may persist longer.
• Need for mechanical ventilation is uncommon in previously healthy term infants.
• Apnea and respiratory failure are more likely in young or premature infants.
• Recurrent wheezing later in childhood is more common after severe viral bronchiolitis, especially with rhinovirus and an atopic background, but bronchiolitis does not itself establish an asthma diagnosis.

Patient Education / Counseling

• Teach caregivers how to use saline drops and gentle nasal suction before feeds and sleep.
• Offer smaller, more frequent feeds and watch urine output as a practical hydration marker.
• Return urgently for pauses in breathing, blue color, marked retractions, inability to feed, fewer wet diapers, unusual sleepiness, or rapidly worsening breathing.
• Explain that antibiotics do not treat uncomplicated viral bronchiolitis.
• Discuss smoke avoidance because tobacco and aerosol exposure can worsen respiratory symptoms.

Notes

Bronchiolitis is a useful test of therapeutic restraint. The child can look dramatically congested and wheezy, but most drug therapies that seem intuitively attractive do not improve the natural course. The clinician adds value by identifying infants who are becoming unable to oxygenate, ventilate, or feed, and by avoiding tests and medications that create harm without changing management.

High-flow therapy has become common, but it should not replace careful clinical assessment. Starting HFNC in every mildly hypoxemic infant can increase resource use without improving meaningful outcomes. Conversely, a child with escalating work of breathing should not remain on HFNC simply because the monitor still shows an acceptable saturation. Respiratory effort, apnea, carbon dioxide, and mental status determine whether support is succeeding.

References

1. American Academy of Pediatrics: Clinical Practice Guideline, Diagnosis and Management of Bronchiolitis — Link
2. Canadian Paediatric Society: Bronchiolitis recommendations for diagnosis, monitoring and management — Link